États-Unis - anglais - NLM (National Library of Medicine)

fenwal, inc. - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr) - anhydrous citric acid 921 mg in 35 ml

États-Unis - anglais - NLM (National Library of Medicine)

fenwal, inc. - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr) - anhydrous citric acid 1.66 g in 63 ml

États-Unis - anglais - NLM (National Library of Medicine)

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - issued 8/96 teruflex® blood bag system with blood sampling arm® cpd/optisol® solution read these instructions carefully before use. instructions for blood collection: use aseptic technique materials needed: venoject® ll tube holder (code p-1316r) venoject® ll multi-sample luer adapter (code mn *2000) venoject® ll plastic blood collection tubes (or equivalent glass or plastic evacuated blood collection tube) 1. confirm that all numbered tubing of each blood bag unit contains segment numbers. 2. make a loose knot in donor tubing below "y" unless alternate methods are used to seal tubing. 3. clamp donor tubing. 4. suspend primary bag as far as possible below the donor's arm. 5. apply blood pressure cuff or tourniquet to donor's arm. disinfect site of phlebotomy. if blood pressure cuff is used, inflate cuff to approximately 60 mmhg. 6. remove needle protector and perform phlebotomy. remove clamp to permit blood flow into primary bag. caution do not touch needle aft

États-Unis - anglais - NLM (National Library of Medicine)

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - 1.1. read these instructions carefully before use. 1.2. rx only. 1.3. intended for the collection, processing and preservation of whole blood and blood components. not intended for direct intravenous infusion. 1.4. for the collection of 450 ml ±10% or 500 ml ±10% whole blood. 1.5. integral diversion blood sampling arm is intended to divert and obtain donor samples for laboratory testing prior to collection of the whole blood unit. 1.6. for further processing, use standard component processing techniques. this device is for use by trained individuals. intended use the donorcare® needle guard is incorporated onto the donor tubing to shield the needle immediately after withdrawal from the donor. single use only. preparation 1. move the donorcare on the tubing ensuring that it slides easily and the arrow is pointing toward the needle hub. 2. ensure that the three lock points on the donorcare are locked closed. whole blood collection 3. perform the phlebotomy as per your institution's standard operating procedures

États-Unis - anglais - NLM (National Library of Medicine)

terumo corporation - trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - trisodium citrate dihydrate 26.3 g in 1000 ml - teruflex® blood bag system cpd/optisol® solution blood bag system read these instructions carefully before use. rx only. intended use collection of 250 ml whole blood: • from elderly, pediatric, or smaller autologous donors who may not tolerate larger blood collections. • for blood collections as directed by a patient's physician. • platelets prepared from 250 ml whole blood collections can only be used for the autologous donation patient. • platelet preparation from a 250 ml whole blood collection are unlikely to meet the 5.5x1010 platelet concentration required by the regulations. instructions for blood collection: use aseptic technique 1. confirm that all numbered tubing of each blood bag unit contains its own identical segment numbers. 2. make a loose knot in the donor tubing approximately 10 cm from the needle. 3. clamp donor tubing with hemastat. 4. suspend primary bag a minimum of 60 cm below the donor's arm 5. apply blood pressure cuff. disinfect site of phlebotomy. inf

États-Unis - anglais - NLM (National Library of Medicine)

terumo corporation - anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), adenine (unii: jac85a2161) (adenine - unii:jac85a2161) - anhydrous citric acid 2.99 g in 1000 ml - full prescribing information *sections or subsections omitted from the full prescribing information are not listed [includes sections 4, 6, 7, 8, 9, 10, 12, 13, 14, 15 and 17]. 1.    indications and usage 1.1.   read these instructions carefully before use. 1.2.   rx only. 1.3.   intended for the collection, processing and preservation of whole blood and blood components. not intended for direct intravenous infusion. 1.4.   for the collection of 450 ml ±10% or 500 ml ±10% whole blood. 1.5.   integral blood sampling arm for obtaining donor samples for laboratory testing after collection of the whole blood unit. 1.6.   for further processing, use standard component processing techniques. donorcare® needle guard this device is for use by trained individuals. intended use the donorcare® needle guard is incorporated onto the donor tubing to shield the needle immediately after withdrawal from the donor. single use only. preparation 1. move the donorcare on the tubing ensuring that it slides ea

États-Unis - anglais - NLM (National Library of Medicine)

medsep corporation - sodium citrate (unii: 1q73q2julr) (citric acid anhydrous - unii:xf417d3psl) - for use with automated plasmapheresis equipment only. use according to equipment manufacturer’s instructions. this unit should be used for plasmapheresis only.

États-Unis - anglais - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - potassium citrate (unii: ee90oni6ff) (anhydrous citric acid - unii:xf417d3psl), citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl) - potassium citrate and citric acid oral solution usp is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. in addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. it is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable. this product is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in recommended dosage. it is highly palatable, pleasant tasting and tolerable, even when administered for l

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

winwa medical sdn. bhd. - citric acid anhydrous; sodium citrate; potassium citrate -

Israël - anglais - Ministry of Health

ferring pharmaceuticals ltd - citric acid anhydrous; magnesium oxide; sodium picosulfate - powder for solution - sodium picosulfate 10 mg; citric acid anhydrous 12 g; magnesium oxide 3.5 g - citric acid - citric acid - to clean the bowel prior to x-ray examination, endoscopy or surgery.